Research
Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma
eLife · By Anand G Patel ·
The Brief
- A multimodal single-cell study in Ewing sarcoma reports fusion-regulated transcriptional programs, according to an eLife article dated 2026-11-11.
- Ewing sarcoma is a fusion-driven malignancy that peaks in adolescence and is driven by EWS::FLI1 and related fusions.
- The source notes that patient outcomes vary greatly and asks whether tumor plasticity of EWS::FLI1-regulated signatures contributes to this variation.
Why it matters
The study addresses why Ewing sarcoma outcomes differ between patients, which could inform future understanding of tumor heterogeneity and treatment response.
Who’s affected
- cancer researchers studying sarcomas and transcriptional regulation
- clinicians and oncology specialists treating pediatric and adolescent bone and soft-tissue tumors
- #ewing sarcoma
- #single-cell
- #transcriptomics
- #oncogenic fusion
- #tumor plasticity
- #cancer biology
Ewing sarcoma (EwS) is a fusion-driven malignancy, peaking in adolescence. Although EwS tumors are driven uniquely by EWS::FLI1 and related fusions, patient outcomes vary greatly. If and how tumor plasticity of EWS::FLI1-regulated transcriptional signatures contributes to disease…
Timeline
eLife published the article Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma
eLife: latest articles
Multimodal single-cell analyses reveal distinct fusion-regulated transcriptional programs in Ewing sarcoma